Administration of the Johnson & Johnson COVID-19 vaccine has been suspended nationwide following news of a rare blood clotting disorder potentially associated with the shot.

According to the Centers for Disease Control (CDC), data is being reviewed involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the one-shot Johnson & Johnson vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis was seen in combination with low levels of blood platelets. All six cases occurred among women between the ages of 18...